CLNT [Cleantech Solutions International] 8-K: (Original Filing)

[Cleantech Solutions International Reports Fourth Quarter and Full Year 2013 Results ● ● Wuxi, Jiangsu Province, China March 31, 2014 “We closed the year with solid financial performance. Full year revenue exceeded expectations and net income nearly doubled, despite the impact of a non-cash impairment charge related to equipment held for operating lease at year end. The primary driver of] [Cleantech Solutions International Announces Conference Call to Discuss Fourth Quarter and Full Year 2013 Financial Results WUXI, Jiangsu, China, March 27, 2014 - Cleantech Solutions International, Inc. ("Cleantech Solutions" or "the Company") (CLNT), a manufacturer of metal components and assemblies, primarily used in the wind power and other industries and dyeing and finishing equipment to the textile industry, today announced] [FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): March 27, 2014 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Nevada 001-34591 90-0648920 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: (Original Filing)

[TABLE OF CONTENTS Page PART I 3 Item 1. Business 3 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 20 Item 2. Properties 20 Item 3. Legal Proceedings 22 Item 4. Mine Safety Disclosures 23 PART II 23 Item 5. 23 Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192657) and Registration Statement on Form S-8 (No. 333-181010) of our report dated March 31, 2014, relating to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and its subsidiaries (collectively the “Company”), which appears in this Annual] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Bing Mei Chief Financial Officer]

By | 2016-03-27T16:14:02+00:00 March 31st, 2014|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-K: TABLE OF CONTENTS Page PART I 3 Item

[TABLE OF CONTENTS Page PART I 3 Item 1. Business 3 Item 1A. Risk Factors 10 Item 1B. Unresolved Staff Comments 20 Item 2. Properties 20 Item 3. Legal Proceedings 22 Item 4. Mine Safety Disclosures 23 PART II 23 Item 5. 23 Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192657) and Registration Statement on Form S-8 (No. 333-181010) of our report dated March 31, 2014, relating to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and its subsidiaries (collectively the “Company”), which appears in this Annual] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this annual report on Form 10-K of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. March 31, 2014 Bing Mei Chief Financial Officer]

By | 2016-03-27T16:15:26+00:00 March 31st, 2014|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

LONG [eLong] S-8: (Original Filing)

[] [[Letterhead of Conyers Dill & Pearman] 31 March, 2014 Matter No: 879238 Doc Ref: DML/RW/jm/6595273.1 (852) 2842 9511 / 2842 9554 David.Lamb@conyersdill.com Rowan.Wu@conyersdill.com eLong, Inc. Dear Sirs, Re: eLong, Inc. (the “Company”) For the purpose of giving this opinion, we have examined copies of the Registration Statement and the Plan. We have also reviewed the third amended and restated memorandum] [Consent of Independent Registered Public Accounting Firm Beijing, People’s Republic of China]

By | 2016-03-28T09:59:55+00:00 March 31st, 2014|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

LONG [eLong] S-8:

[] [[Letterhead of Conyers Dill & Pearman] 31 March, 2014 Matter No: 879238 Doc Ref: DML/RW/jm/6595273.1 (852) 2842 9511 / 2842 9554 David.Lamb@conyersdill.com Rowan.Wu@conyersdill.com eLong, Inc. Dear Sirs, Re: eLong, Inc. (the “Company”) For the purpose of giving this opinion, we have examined copies of the Registration Statement and the Plan. We have also reviewed the third amended and restated memorandum] [Consent of Independent Registered Public Accounting Firm Beijing, People’s Republic of China]

By | 2016-03-28T10:02:14+00:00 March 31st, 2014|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

LONG [eLong] 20-F: (Original Filing)

[TABLE OF CONTENTS Page PART I 5 Item 1: Identity of Directors, Senior Management and Advisers 5 Item 2: Offer Statistics and Expected Timetable 5 Item 3: Key Information 5 Item 4: Information on the Company 22 Item 4A: Unresolved Staff Comments 34 Item 5: Operating and Financial Review and Prospects 34 Item 6: Directors, Senior Management and Employees 50] [* ELONG, INC. SECTION 1. Purpose; Definitions The purpose of the Plan is to give the Company a competitive advantage in attracting, retaining and motivating officers, employees, directors and consultants and to provide the Company and its Affiliates with a share and incentive plan granting Awards to provide incentives directly linked to shareholder value. Certain terms used herein have definitions] [Power of Attorney China Company I, Guangfu Cui, a citizen of the People’s Republic of China (“ Authorize the Authorized Party to have full rights and authority to represent me, in my name as holder of 1.67% equity interest, according to laws and company articles of incorporation, to exercise any and all shareholder rights, including but not limited to: the] [Declaration and Undertaking To eLongNet Information Technology (Beijing) Co., Ltd. (“WFOE”) No. 10 Middle Jiuxianqiao Road, Chaoyang District, Beijing eLong, Inc. th 4 Declaration and Undertaking This CUI Guangfu (“Party A”) Residence: No.1, XiangHongqi Street, Haidian District, Beijing ID No.: [] HUANG Chunhua (Spouse) ( Party B ) “ Residence: No.1, XiangHongqi Street, Haidian District, Beijing ID Number: [] Whereas:] [Amendment to the Sixth Amended and Restated Loan Agreement This amendment was executed on August 15, 2013 in Beijing by the following parties: eLong, Inc. (“Party A”) : Legal Address Cayman, Cayman Islands Guangfu Cui (“Party B”) Residence: No.1, XiangHongqi Street, Haidian District, Beijing ID No.: [ ] Each party hereto shall be called a “Party” and together the “Parties”] [Amendment to the Equity Interests Pledge Agreement This Amendment was executed on August 15, 2013 in Beijing by the following parties: Pledgee eLongNet Information Technology (Beijing) Co., Ltd. Address: 10 Jiuxianqiao Middle Road, Chaoyang District, Beijing Legal Representative: Guangfu Cui Pledgor Guangfu Cui Address: No.1, XiangHongqi Street, Haidian District, Beijing ID No.: [] Each party hereto shall be referred to] [Amendment to the Sixth Amended and Restated Business Operations Agreement This Amendment was executed on August 15, 2013 in Beijing by the following parties: Party A: Address: Legal Representative: Party B: Address: nd Legal Representative: Party C: Address: ID No.: WHEREAS: 1. On December 26, 2012, Party A and Party B entered into the Sixth Amended and Restated Business Operations] [Subsidiaries • eLongNet Information Technology (Beijing) Co., Ltd., a PRC company. • eLong Information Technology (Hefei) Co., Ltd., a PRC company Consolidated Affiliated Entities • Beijing eLong Information Technology Co., Ltd., a PRC company. • Beijing eLong Air Services Co., Ltd., a PRC company. • Beijing eLong International Travel Co., Ltd., a PRC company. • Beijing Asia Media Interactive Advertising] [I, Guangfu Cui, certify that: 1. I have reviewed this annual report on Form 20-F of eLong, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [I, Rong Luo, certify that: 1. I have reviewed this annual report on Form 20-F of eLong, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [eLong, Inc. Company Report (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of December 31, 2013 and results of operations of the Company for the year ended December 31, 2013. Guangfu Cui Chief Executive Officer March 31, 2014] [eLong, Inc. Certification of Principal Financial Officer Company Report (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition of the Company as of December 31, 2013 and results of operations of the Company for the year ended December 31, 2013. Rong Luo Chief Financial Officer March 31, 2014] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statement (Form S-8 No. 333-126381) pertaining to the eLong, Inc. Stock Option Plan dated April 18, 2001 and the eLong, Inc. Stock and Annual Incentive Plan dated July 23, 2004; (2) Registration Statement (Form S-8 No. 333-166722) pertaining to] [Consent of DaHui Lawyers [Letterhead of DaHui Lawyers] March 31, 2014 eLong, Inc. Block B, Xingke Plaza Building 10 Middle Jiuxianqiao Road Chaoyang District, Beijing 100015 People’s Republic of China Dear Sirs: Yours faithfully,]

By | 2016-03-28T10:04:36+00:00 March 31st, 2014|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

EVK [Ever-Glory International] NT 10-K: Former name if applicable: Ever-Glory Commercial Center, 509

[Former name if applicable: Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, Peoples Republic of China City, state and zip code]

BSPM [Biostar Pharmaceuticals] 10-K: (Original Filing)

[FORM 10-K (Mark One) x December 31, 2013 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192963) of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [CERTIFICATION I, Ronghua Wang, certify that: 1. R e I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Qinghua Liu, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: March 31, 2014 Ronghua Wang Chief Executive Officer EX-32.1 5 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: March 31, 2014 Qinghua Liu Interim Chief Financial Officer (principal financial officer) EX-32.2 6 ex32-2.htm EX-32.2]

By | 2016-03-28T18:34:02+00:00 March 31st, 2014|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals] 10-K: FORM 10-K (Mark One) x December 31, 2013

[FORM 10-K (Mark One) x December 31, 2013 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 86-29-33686638 (Former name, former] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-192963) of Biostar Pharmaceuticals, Inc. of our report dated March 31, 2014 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [CERTIFICATION I, Ronghua Wang, certify that: 1. R e I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Qinghua Liu, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: March 31, 2014 Ronghua Wang Chief Executive Officer EX-32.1 5 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Dated: March 31, 2014 Qinghua Liu Interim Chief Financial Officer (principal financial officer) EX-32.2 6 ex32-2.htm EX-32.2]

By | 2016-03-28T18:35:49+00:00 March 31st, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar